Copenhagen biotech boom faces US-China competition for talent and capital

Copenhagen has become a hub for biotech startups, with hundreds of new medicines in development, but the sector faces headwinds from US and Chinese competition for funding and talent. The long-term retention of these companies is uncertain, as Europe's role in drug development is challenged by more aggressive innovation ecosystems elsewhere.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works